Serono Labs Pleads Guilty To Criminal Conspiracy Charges In Serostim Case

Serono Inc., which reached a $704 mil. settlement with federal and state prosecutors, says its brand products will remain available under federal healthcare programs despite the guilty plea by its U.S. affiliate.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet